Future Fertility is a fertility technology company developing AI-enabled and non-invasive fertility solutions to optimize clinical decision making in fertility care and in vitro fertilization (IVF). Future Fertility was co-founded in 2017 by Dr Dan Nayot, internationally renowned and practicing reproductive endocrinologist. Future Fertility’s first non-invasive AI solution can detect features of a human egg that are invisible to the eye and can predict the likelihood of fertilization and embryo (blastocyst) development. Beyond its flagship egg prediction software product “Violet” developed for patients underdoing oocyte cryopreservation, Future Fertility has additional AI solutions in its pipeline.
Future Fertility's AI-powered oocyte-assessment tools receive CE Mark under the new European Union Medical Device Regulation (MDR)
2022/05/02Future Fertility today announced that Christine Prada has been named as Chief Executive Officer. Her employment with Future Fertility will commence in early May.
2022/01/06First company to develop an AI product to predict egg viability with potential to significantly improve IVF outcomes
Financing led by M Ventures with participation from Whitecap Venture Partners
